HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Effects of beta 1- and beta 1 + beta 2-antagonists on training-induced myocardial hypertrophy and enzyme adaptation.

Abstract
The effects of beta 1- and beta 1 + beta 2-antagonists on the myocardial adaptation to exercise training were investigated in male Sprague-Dawley rats randomly divided into trained (treadmill, 1 hr/day, 5 days/week for 10 weeks at 27 m/min, 15% grade) without drug (TC), sedentary without drug (SC), trained treated with atenolol (TA) (10 mg/kg body wt, i.p.), trained treated with propranolol (TP, 30 mg/kg body wt, i.p.), and sedentary propranolol. Doses of both beta-antagonists were titrated to decrease the exercise heart rate by 25% compared to the controls. The heart weight and heart/body weight ratio were significantly greater in TC (1.28 +/- 0.07 g (P less than 0.01); 296 +/- 12 mg/100 g body wt (P less than 0.05) respectively) than in SC (1.09 +/- 0.04 g and 268 +/- 11 mg/100 g body wt), or in TP and TA. Myocardial mitochondrial protein was unchanged by training or beta-blockade. Citrate synthase and beta-hydroxyacyl CoA dehydrogenase activities were not altered. Carnitine palmitoyltransferase activity was increased in SP compared to SC. Training increased hexokinase activity only in TC (5.22 +/- 0.12 vs 4.26 +/- 0.23 mumol/min/g wet wt, P less than 0.01). Lactate dehydrogenase activity increased significantly (P less than 0.01) in both TC (383 +/- 14 mumol/min/g wet wt) and TA (372 +/- 14 mumol/min/g wet wt) compared to SC (276 +/- 14 mumol/min/g wet wt), but not in TP versus SP. These data indicate that (1) beta-adrenergic blockade prevents training-induced cardiac hypertrophy; (2) beta-antagonists have little effect on the myocardial oxidative capacity; and (3) while the training induction of myocardial hexokinase is inhibited by both beta 1- and beta 1 + beta 2-antagonists, myocardium may increase its ability to utilize lactate during exercise with training despite beta 1-blockade.
AuthorsL L Ji, F W Stratman, H A Lardy
JournalBiochemical pharmacology (Biochem Pharmacol) Vol. 36 Issue 20 Pg. 3411-7 (Oct 15 1987) ISSN: 0006-2952 [Print] England
PMID2890350 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Adrenergic beta-Antagonists
  • Lactates
  • Proteins
  • Lactic Acid
  • 3-Hydroxyacyl CoA Dehydrogenases
  • L-Lactate Dehydrogenase
  • Carnitine O-Palmitoyltransferase
  • Citrate (si)-Synthase
  • Hexokinase
Topics
  • 3-Hydroxyacyl CoA Dehydrogenases (analysis)
  • Adaptation, Physiological (drug effects)
  • Adrenergic beta-Antagonists (pharmacology)
  • Animals
  • Body Weight (drug effects)
  • Cardiomegaly (prevention & control)
  • Carnitine O-Palmitoyltransferase (analysis)
  • Citrate (si)-Synthase (analysis)
  • Heart Rate (drug effects)
  • Hexokinase (analysis)
  • L-Lactate Dehydrogenase (analysis)
  • Lactates (metabolism)
  • Lactic Acid
  • Male
  • Myocardium (enzymology)
  • Oxidation-Reduction
  • Physical Education and Training
  • Proteins (analysis)
  • Rats
  • Rats, Inbred Strains

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: